Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid Tumors. - Brea EJ; Baldacci S; Savage N; Facchinetti F; Hinchey C; Chakravarti S; Mottram A; Ngo K; Vo H; Leeper BA; Tuladhar B; Ganapathy S; et al. (Cancer immunology research, 2025)